Cargando…

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

INTRODUCTION: Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-month regimen comprised of bedaquiline, the new drug pretomanid and linezolid, endorsed by the WHO for use under operational research conditions in patients with extensively drug-resistant tuberculosis (XDR-TB). We quant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulder, Christiaan, Rupert, Stephan, Setiawan, Ery, Mambetova, Elmira, Edo, Patience, Sugiharto, Jhon, Useni, Sani, Malhotra, Shelly, Cook-Scalise, Sarah, Pambudi, Imran, Kadyrov, Abdullaat, Lawanson, Adebola, van den Hof, Susan, Gebhard, Agnes, Juneja, Sandeep, Sohn, Hojoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739433/ https://www.ncbi.nlm.nih.gov/pubmed/34992077 http://dx.doi.org/10.1136/bmjgh-2021-007182

Ejemplares similares

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
por: van de Berg, S. E. J., et al.
Publicado: (2021)

1400. Pretomanid in the Treatment of Patients with Tuberculosis in the United States: the Bedaquiline, Pretomanid and Linezolid (BPaL) Accelerated Monitoring (BAM) Project
por: Goswami, Neela, et al.
Publicado: (2021)

2354. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for rifampin-resistant or treatment-intolerant TB disease
por: Haley, Connie A, et al.
Publicado: (2022)

Budgetary control in academic libraries
por: Martin, Murray S
Publicado: (1978)

Notes and Proposals on Budgetary Calculations
Publicado: (1962)

Budgetary Arrangements for the ISR Programme in the Future
Publicado: (1970)

Budgetary Arrangements for the ISR Programme in the Future
Publicado: (1970)

Budgetary Arrangements for the ISR Programme in the Future
Publicado: (1970)

Examination of the Consequences of Suggested Budgetary Cuts
Publicado: (1957)

Assessment of GeneXpert MTB/RIF Performance by Type and Level of Health-Care Facilities in Nigeria
por: Gidado, Mustapha, et al.
Publicado: (2019)

Sugammadex: Appropriate Use in the Context of Budgetary Constraints
por: Cammu, Guy
Publicado: (2018)

Are BPA Substitutes as Obesogenic as BPA?
por: Oliviero, Fabiana, et al.
Publicado: (2022)

Proposal for an expanded methodology for presenting the Organization’s financial and budgetary position
Publicado: (2021)

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone(®)) in Spain
por: Martinez-Raga, Jose, et al.
Publicado: (2012)

WHO's budgetary allocations and burden of disease: a comparative analysis
por: Stuckler, David, et al.
Publicado: (2008)

Bisphenol-A (BPA) in Foods commonly consumed in Southwest Nigeria and its Human Health Risk
por: Adeyi, Adebola A., et al.
Publicado: (2019)

Prenatal Exposure to BPA and Offspring Outcomes: The Diabesogenic Behavior of BPA
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2015)

Request for Authorization to Exceed the Budgetary Appropriation for the Symposium Held in June 1956
Publicado: (1956)

A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact
por: Marseille, Elliot, et al.
Publicado: (2016)

The budgetary impact of alemtuzumab in multiple sclerosis in Quito, Ecuador. Payer’s perspective
por: Pastor-Quirós, Luis J., et al.
Publicado: (2021)

Contact Tracing and Tuberculosis Preventive Therapy for Household Child Contacts of Pulmonary Tuberculosis Patients in the Kyrgyz Republic: How Well Are We Doing?
por: Kadyrov, Meder, et al.
Publicado: (2023)

Summary of the Budgetary and Financial Situation after the 99th Meeting of the Finance Committee
Publicado: (1969)

Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain
por: Jiménez-Ruiz, Carlos A, et al.
Publicado: (2015)

Effects of BPA in Snails
por: Dietrich, Daniel R., et al.
Publicado: (2006)

Essential managerial skills for financial and budgetary management in medical universities: The top managers' perspective
por: Javani, Ali, et al.
Publicado: (2017)

Budgetary targets as cost-containment measure in the Swiss healthcare system? Lessons from abroad()
por: Braendle, Thomas, et al.
Publicado: (2020)

Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021
por: Kyrbashov, Bolot, et al.
Publicado: (2023)

Molecular Mechanisms of Action of BPA
por: Acconcia, Filippo, et al.
Publicado: (2015)

Teratogenicity and toxicity of the new BPA alternative TMBPF, and BPA, BPS, and BPAF in chick embryonic development
por: Harnett, Kristen G., et al.
Publicado: (2021)

Amendment to Document ""Summary of the Budgetary and Financial Situation after the 99th Meeting of the Finance Committee""
Publicado: (1969)

A scoping review of public hospitals autonomy in Iran: from budgetary hospitals to corporate hospitals
por: Sohrabi, Rahim, et al.
Publicado: (2021)

“Together against Tuberculosis”: Cascade of Care of Patients Referred by the Private Health Care Providers in the Kyrgyz Republic
por: Madybaeva, Dinara, et al.
Publicado: (2023)

Triple Priority: TB/HIV Co-Infection and Treatment Outcomes among Key Populations in The Kyrgyz Republic: A National Cohort Study (2018–2022)
por: Goncharova, Olga, et al.
Publicado: (2023)

Chemical Exposures: No Dental Dilemma for BPA
por: Josephson, Julian
Publicado: (2006)

Bisphenol A (BPA) the mighty and the mutagenic
por: Jalal, Nasir, et al.
Publicado: (2017)

The Case for BPA as an Obesogen: Contributors to the Controversy
por: Rubin, Beverly S., et al.
Publicado: (2019)

Neuro-toxic and Reproductive Effects of BPA
por: Santoro, Antonietta, et al.
Publicado: (2019)

Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection
por: Chaillon, Antoine, et al.
Publicado: (2019)

Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs
por: Rubio-Terrés, Carlos, et al.
Publicado: (2020)

HOW TO BUDGET FOR COVID-19 RESPONSE?: A rapid scan of budgetary mechanisms in highly affected countries
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4288e3ts62mgnnsabdcuv0ffli